Louise K. D. Fensholdt

INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis

J. Jelsing, N. Vrang, Kristoffer T. G. Rigbolt, 2018, World journal of gastroenterology.

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH

J. Jelsing, N. Vrang, L. Adorini, 2019, Scientific Reports.

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH

J. Jelsing, N. Vrang, L. Adorini, 2019, Scientific Reports.